Unlock instant, AI-driven research and patent intelligence for your innovation.

Cgap-pna multivalent peptide nucleic acid ligand display

A peptide nucleic acid and amino acid technology, applied in the field of cGAP‑PNA multivalent peptide nucleic acid ligand display, can solve the problem that the number of ligands cannot be strictly limited

Inactive Publication Date: 2016-11-23
UNITED STATES OF AMERICA
View PDF2 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Unfortunately, these larger systems are heterogenous mixtures where the number of ligands on each scaffold cannot be strictly defined

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Cgap-pna multivalent peptide nucleic acid ligand display
  • Cgap-pna multivalent peptide nucleic acid ligand display
  • Cgap-pna multivalent peptide nucleic acid ligand display

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0082] In the preparation of the constructs of the invention, gamma-substituents may be introduced based on their function in the interaction with specific receptors or other biological interaction sites. In a particular PNA, more than one substituent may be utilized. In a particular L-PNA:PNA(GAP) scaffold, different L-PNAs may contain the same or different substituents depending on the target moiety.

[0083] In addition to the PNAs described above, any of a variety of PNA variations known in the art may be used. Known PNA macromolecules include macromolecules represented by the following structures.

[0084]

[0085] Natural and unnatural bases can be used in these structures and are well known to those skilled in the art.

[0086] Scheme 1 depicts a method for the synthesis of γ-substituted monomers that can be used to prepare L-PNA. The gamma substituents can serve as points for further functionalization. These monomers can be converted to L-PNA by methods known in...

Embodiment 1

[0122] This example demonstrates the generation of an initial library of ligand-modified PNA conjugates and the multivalent profile of the conjugates according to one embodiment of the invention.

[0123] To generate a multivalent library of ligand-modified PNA conjugates (L-PNA), the high-affinity AR antagonist, xanthine amine congener (XAC), was synthesized via a γ-side chain derived from lysine (γ- Lys) conjugated to PNA oligomer ( Figure 1A). Ligands attached to this side chain within the L-PNA oligomer do not interfere with the ability of L-PNA to bind complementary DNA sequences via conventional Watson Crick base pairing. A series of PNA oligomers (each consisting of 12 nucleobases) were synthesized in which one, two or three γ-Lys side chains were incorporated into the sequence ( Figures 1B-1D ). The primary amine at the end of the side chain of γ-Lys serves as the attachment point for the XAC ligand. Two mini-PEG (8-amino-3,6-dioxahanoic acid) linkers inserted bet...

Embodiment 2

[0128] This example demonstrates ligand spacing on the binding of L-PNA:DNA complexes according to one embodiment of the invention.

[0129] The initial results obtained showed that the L-PNA:DNA complex carrying two XAC ligands bound significantly better than the corresponding monovalent complex. Next, the effect of ligand spacing was assessed. Examine a series of bivalent constructs in which the two γ-Lys side chains carrying the XAC ligand are systematically displaced along the PNA backbone ( Figure 3A-3B ). To minimize the electrostatic impact of negative charges on the DNA phosphodiester backbone, the DNA was replaced with a sequence-complementary PNA. It was established that PNA:PNA duplexes maintain regular nucleobase pairing in the double helix. Experimental results suggest that DNA may have a negative effect on binding because A1 P than A1 D Effective 8-fold (p=0.0015). The resulting L-PNA:PNA duplex is charge-neutral and does not undergo charge-charge with the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Described herein are compositions composed of peptide nucleic acid strands. In some aspects the peptide nucleic acid strands are complementary to at least a portion of another peptide nucleic acid strand that may have one or more gamma substituents, where the ratio of PNA strands is least 1:1. Certain gamma substituents are capable of effecting attachment of a PNA strand to a cell. The disclosure also concerns construction of nanostructure platforms and vaccines and use of the inventive compositions in inhibiting disease states in mammals.

Description

[0001] Cross References to Related Applications [0002] This patent application claims the benefit of US Provisional Patent Application No. 61 / 929,893, filed January 21, 2014, which is incorporated by reference. Background of the invention [0003] A multivalent (or polyvalent) interaction refers to the simultaneous binding of multiple ligands on the surface of a molecular entity to multiple receptors on another. The strength and specificity of multivalent interactions depend on the cumulative effects of all ligands and all receptors involved in the process. In a multivalent array, a single isolated ligand-receptor interaction may actually be weak, but the combined effect of multiple ligand-receptor interactions may be very strong. Such multivalent interactions occur throughout biology and are important in many processes, such as those involving cell surface receptors. For example, cell attachment, wound healing, and immune responses are basic examples where multivalent int...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K47/48C07K14/00A61P31/00A61P31/18A61P35/00
CPCC07K14/003A61K47/549A61P31/00A61P31/18A61P35/00A61K39/00G01N33/532G01N33/68G01N2333/705A61K51/0497A61K2039/6025C12N15/117C12N2310/151C12N2310/3181C12N2310/3513C12N2310/52
Inventor 丹尼尔·H·阿佩拉安德鲁·V·迪克斯伊桑·英格伦卡拉·乔治·罗森克尔
Owner UNITED STATES OF AMERICA